 |
 |
Martin Rogers (born 1981) is an Australian bioentrepreneur who has been associated since 2007 with a number of ASX-listed biotechnology companies, including Prima BioMed, which he led from 2007 to 2012.
|
|
Martin Rogers (born 1981) is an Australian bioentrepreneur who has been associated since 2007 with a number of ASX-listed biotechnology companies, including Prima BioMed, which he led from 2007 to 2012.
Rogers attended the University of New South Wales between 1999 and 2004 where he gained a double degree in chemical engineering and computer science. Between 2004 and 2007 he engaged in a number of entrepreneurial pursuits as well as worked at Macquarie Bank. [1]
Rogers was part of an investor group that effectively took control of Prima BioMed in late 2007, when he was appointed a director. At that time Prima had Phase IIa data for its CVac cancer vaccine product, but did not have the funds to progress further. Under Rogers' leadership Prima achieved four main things:
* Raised approx. A$82m in new capital. Rogers started with a 1-for-2 rights issue in October 2007 (A$2.0m) [2] and followed with Share Purchase Plans in December 2008 [3] and June 2009 [4] (each approx A$0.2m) and a share placement in June 2009 (A$1.5m) [5] before securing an equity funding line which allowed A$14.7m to be raised between July 2011 and March 2011. From late 2009 capital raising became easier. A third Share Purchase Plan in December 2009 raised A$13.7m [6] while a placement and associated Share Purchase Plan in June 2011 raised A$41.4m. [7] Between 2009 and 2012 the exercise of options brought in another A$8.4m (A$1.3m in 2009/10, [8] A$5.1m in 2010/11 [9] and A$2.0m in 2011/12 [10] ).
* Experienced an increase in its share price. Prima stock re-rated 19-fold between December 2007 and April 2011, creating a company with a market value of ~A$300m. [11]
* Moved CVac into mid-stage clinical studies. The extra funding Prima was able to raise allowed CVac to be taken into Phase IIb studies from 2010 with a runway into Phase III.
* Became a Nasdaq-listed company. Prima's ADRs started trading on Nasdaq in April 2012.
Prima announced in May 2012 that Rogers would be stepping down as CEO. [12] He left Prima at the end of August 2012. By the end of tenure Prima had made it into the S&P/ASX 300. [13]
Since 2012 Rogers has been involved at board level in a number of ASX-listed biotech companies, including Cellmid (ASX: CDY) between September 2012 [14] and June 2015; [15] Rhinomed (ASX: RNO), since September 2012; [16] OncoSil Medical (ASX: OSL) since April 2013; [17] and Actinogen (ASX: ACW), since September 2014. [18]
In 2018, Martin Rogers, of KTM Ventures, co-invested with Mike Tilley to purchase a 30% stake in cryptocurrency exchange Independent Reserve. [19] [20]
BlueScope Steel Limited is an Australian flat product steel producer that was spun-off from BHP Billiton in 2002.
Brambles Limited is an Australian company that specialises in the pooling of unit-load equipment, pallets, crates and containers. It is listed on the Australian Securities Exchange.
Downer Group is an integrated services company active in Australia and New Zealand.
Carlton & United Breweries (CUB) is an Australian brewing company based in Melbourne and owned by Japanese conglomerate Asahi Breweries. Its notable brands include Victoria Bitter, Carlton Draught, Foster's Lager, Great Northern, Resch's, Pure Blonde and Melbourne Bitter.
ReelTime Media Ltd or ReelTime.tv was an Internet-based Australian video on demand and electronic sell-through provider. It was founded in 2005 and went public in April 2006 with its service launched beta in November 2006, and fully commercial in February 2007.
The Wiluna Gold Mine is an inactive gold mine in Western Australia near the town of Wiluna. The mine was active from 1984 until its closure in 2007 when it was put into care and maintenance, and again from late 2008 to June 2013 when the owners, APEX Minerals, went into receivership. Following this, the mine had been placed in care and maintenance again in 2013. In January 2014 it was announced that the mine would be sold to Blackham Resources, with the deal to be finalised by March 2014. Mining resumed in 2016 and Blackham was renamed to Wiluna Mining Corporation in 2020. In July 2022, the Wiluna Mining Corporation entered voluntary administration, with mining ceasing in December 2022 and processing in February 2023.
The BrightStar Gold Mine is a gold project located 35 km south-east of Laverton, Western Australia. Operations at Brightstar are suspended with the processing plant under care and maintenance.
The Mount Ida Gold Mine is a gold mine located 86 km north-west of Menzies, Western Australia.
The Gidgee Gold Mine is a gold mine in Western Australia, 82 km north of the town of Sandstone. The mine was, until recently, owned by APEX Minerals NL, but purchased by Panoramic Resources in February 2011. The mine is currently in care and maintenance and owned by Horizon Gold, having purchased the mine in 2016.
The Edna May Gold Mine is a gold mine located at Westonia, Western Australia.
Speedcast is a company specializing in communications satellite technology. According to their website, they claim to have "more satellite capacity than any other service provider combined with an extensive multi-technology terrestrial and offshore network ." Speedcast has grown through organic and inorganic growth to be one of the major satellite service providers in the Asia-Pacific, Middle East, Europe, and Africa regions, with a global maritime network serving customers worldwide. The company serves over 350 customers across more than 2,000 terrestrial sites in approximately 50 countries, and more than 1,187 maritime vessels and offshore rigs.
Nathan Tinkler is an Australian mining industry executive and was previously the principal shareholder of Aston Resources and Whitehaven Coal. He started out as a mining apprentice in the Hunter Valley, in New South Wales and set up his own business at age 26. Much of his wealth was acquired from investments in the mining industry.
CVac, is an immunotherapeutic agent that was 1st developed in Australia.
Gage Roads Brew Co is an Australian craft brewery located just outside the city of Fremantle in Palmyra, Western Australia. It is one of Australia's largest independent breweries. In 2016, its new-world pale ale - "Little Dove" - was awarded the Trophy for Champion Australian Beer at the 2016 Australian International Beer Awards. In 2015, it was runner-up Champion Large Brewery at the Australian International Beer Awards.
Immutep Ltd is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech.
Peet Limited is an Australian real estate development company focused on creating masterplanned residential communities and medium density and apartment developments for homebuyers across Australia.
CI Resources is an ASX listed company which operates the phosphate mine and provides services to the Immigration Reception and Processing Centre on Christmas Island.
China Railway Materials Commercial Corp. is a state-owned company of China, under the supervision of State-owned Assets Supervision and Administration Commission of the State Council.
Webster Limited is an Australian business founded in 1831 by Alexander Webster, just 28 years after the settlement of Van Diemen's Land. Founded as a traditional pastoral house, Webster Limited is now a diversified food and agribusiness. Webster Limited acquired the Riverina walnut assets from Gunns Limited in 2010 and is now Australia and the southern hemisphere's largest walnut grower through its ownership and/or management of more than 2,200ha of orchards in Tasmania and the Riverina. Webster has since diversified into cotton and livestock following their A$ 116 million purchase of the 40,000-hectare prime Riverina cropping aggregation, "Kooba", in 2010.
Nutrien is a Canadian fertilizer company based in Saskatoon, Saskatchewan. It is the largest producer of potash and the third largest producer of nitrogen fertilizer in the world. It has over 2,000 retail locations across North America, South America, and Australia with more than 23,500 employees. It is listed on the Toronto Stock Exchange and New York Stock Exchange, with a market capitalization of $34 billion as of January 2018. It was formed through the merger of PotashCorp and Agrium, in a transaction that closed on January 1, 2018.